Senior insider sale
Chief Legal & Admin. Officer at SYROS PHARMACEUTICALS, INC. — senior position signals high conviction
$16.8K
49.76K shares
What this filing means
QUIRK GERALD E plans to sell 49.76K shares of SYROS PHARMACEUTICALS, INC. valued at approximately $16.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/19/2024ACC: 0001972362-24-001685
Officer· Chief Legal & Admin. Officer
Since Feb 2019
49.76K
Shares to sell
$16.8K
Approx. market value
46.66K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months4
RESTRICTED STOCK
COMPENSATION
9/30/2024
6.90KRESTRICTED STOCK
COMPENSATION
3/24/2024
15.45KRESTRICTED STOCK
COMPENSATION
10/18/2023
15.60KRESTRICTED STOCK
COMPENSATION
3/31/2022
8.70KTotal acquired46.66K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/30/2024 | RESTRICTED STOCK COMPENSATION | 6.90K | — |
3/24/2024 | RESTRICTED STOCK COMPENSATION | 15.45K | — |
10/18/2023 | RESTRICTED STOCK COMPENSATION | 15.60K | — |
3/31/2022 | RESTRICTED STOCK COMPENSATION | 8.70K | — |
| Total | 46.66K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.10K
Market value
$6.5K
10/1/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
46.66K
Market value
$10.3K
11/19/2024
Total
Units
49.76K
Value
$16.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/1/2024 | 3.10K | $6.5K | — | Completed |
| Planned — Approximate Date | ||||
11/19/2024 | 46.66K | $10.3K | NASDAQ | Planned |
| Total | 49.76K | $16.8K | ||